Aflac (AFL)

AFL boosts its buyback plan to 130.9M shares as strong sales in Japan and higher U.S. margins fuel shareholder returns.

AFL's Q2 earnings benefit from robust Japan cancer insurance sales and strong persistency rates in the U.S. business, partly offset by rising costs.

Aflac Incorporated (NYSE:AFL ) Q2 2025 Earnings Call August 6, 2025 8:00 AM ET Company Participants Daniel Paul Amos - Chairman & CEO David Young - Corporate Participant Koichiro Yoshizumi - Senior Ma...

While the top- and bottom-line numbers for Aflac (AFL) give a sense of how the business performed in the quarter ended June 2025, it could be worth looking at how some of its key metrics compare to Wa...

Aflac (AFL) came out with quarterly earnings of $1.78 per share, beating the Zacks Consensus Estimate of $1.71 per share. This compares to earnings of $1.83 per share a year ago.

Health and life insurer Aflac on Tuesday beat Wall Street estimates for second quarter profit, driven by steady premium gains in the United States offset investment losses.

Here, we take a look at four insurance stocks, AFL, LMND, HRTG and AIZ, which are set to report second-quarter earnings on Aug. 5.

AFL braces for Q2 results with EPS likely to decline 6.6% and revenue off 13.7% as U.S. and Japan earnings face pressure.

Evaluate the expected performance of Aflac (AFL) for the quarter ended June 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for be...

Aflac (AFL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.